These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeys. Burel SA; Han SR; Lee HS; Norris DA; Lee BS; Machemer T; Park SY; Zhou T; He G; Kim Y; MacLeod AR; Monia BP; Lio S; Kim TW; Henry SP Nucleic Acid Ther; 2013 Jun; 23(3):213-27. PubMed ID: 23692080 [TBL] [Abstract][Full Text] [Related]
6. Local and systemic tolerability of a 2'O-methoxyethyl antisense oligonucleotide targeting interleukin-4 receptor-α delivery by inhalation in mouse and monkey. Fey RA; Templin MV; McDonald JD; Yu RZ; Hutt JA; Gigliotti AP; Henry SP; Reed MD Inhal Toxicol; 2014 Jul; 26(8):452-63. PubMed ID: 24932560 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression. Geary RS; Leeds JM; Fitchett J; Burckin T; Truong L; Spainhour C; Creek M; Levin AA Drug Metab Dispos; 1997 Nov; 25(11):1272-81. PubMed ID: 9351904 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of SPECT-CT Imaging to Study the Pharmacokinetics of Antisense Oligonucleotides in a Mouse Model of Duchenne Muscular Dystrophy. van de Steeg E; Läppchen T; Aguilera B; Jansen HT; Muilwijk D; Vermue R; van der Hoorn JW; Donato K; Rossin R; de Visser PC; Vlaming MLH Nucleic Acid Ther; 2017 Aug; 27(4):221-231. PubMed ID: 28418733 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species. Geary RS; Yu RZ; Watanabe T; Henry SP; Hardee GE; Chappell A; Matson J; Sasmor H; Cummins L; Levin AA Drug Metab Dispos; 2003 Nov; 31(11):1419-28. PubMed ID: 14570775 [TBL] [Abstract][Full Text] [Related]
10. Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-myc oncogene in cynomolgus monkeys. Webb MS; Tortora N; Cremese M; Kozlowska H; Blaquiere M; Devine DV; Kornbrust DJ Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):155-63. PubMed ID: 11446591 [TBL] [Abstract][Full Text] [Related]
12. Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys. Yu RZ; Gunawan R; Post N; Zanardi T; Hall S; Burkey J; Kim TW; Graham MJ; Prakash TP; Seth PP; Swayze EE; Geary RS; Henry SP; Wang Y Nucleic Acid Ther; 2016 Dec; 26(6):372-380. PubMed ID: 27500733 [TBL] [Abstract][Full Text] [Related]
13. Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy. Heemskerk H; de Winter CL; van Ommen GJ; van Deutekom JC; Aartsma-Rus A Ann N Y Acad Sci; 2009 Sep; 1175():71-9. PubMed ID: 19796079 [TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290 [TBL] [Abstract][Full Text] [Related]
15. Integrated Assessment of the Clinical Performance of GalNAc Crooke ST; Baker BF; Xia S; Yu RZ; Viney NJ; Wang Y; Tsimikas S; Geary RS Nucleic Acid Ther; 2019 Feb; 29(1):16-32. PubMed ID: 30570431 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and toxicity profile of a phosphorothioate oligonucleotide following inhalation delivery to lung in mice. Templin MV; Levin AA; Graham MJ; Aberg PM; Axelsson BI; Butler M; Geary RS; Bennett CF Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):359-68. PubMed ID: 11079575 [TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of the effects of a novel antisense compound targeting C-raf kinase in mice and monkeys. Monteith DK; Geary RS; Leeds JM; Johnston J; Monia BP; Levin AA Toxicol Sci; 1998 Dec; 46(2):365-75. PubMed ID: 10048140 [TBL] [Abstract][Full Text] [Related]
18. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422 [TBL] [Abstract][Full Text] [Related]